

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 6.30601233 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.07516937 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 6.00101121 |
| 4 | * regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.98952861 |
| 5 | * synaptic vesicle maturation (GO:0016188) | 5.81945056 |
| 6 | vocalization behavior (GO:0071625) | 5.67922398 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.52634353 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.42711994 |
| 9 | glutamate secretion (GO:0014047) | 5.39426154 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.20912942 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.10147561 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.86781163 |
| 13 | protein localization to synapse (GO:0035418) | 4.86680238 |
| 14 | exploration behavior (GO:0035640) | 4.80015755 |
| 15 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.70917195 |
| 16 | regulation of synaptic vesicle transport (GO:1902803) | 4.62304229 |
| 17 | layer formation in cerebral cortex (GO:0021819) | 4.62131426 |
| 18 | * regulation of neuronal synaptic plasticity (GO:0048168) | 4.59498877 |
| 19 | regulation of synapse structural plasticity (GO:0051823) | 4.57260992 |
| 20 | cerebellar granule cell differentiation (GO:0021707) | 4.55033368 |
| 21 | neuronal action potential propagation (GO:0019227) | 4.49650752 |
| 22 | * neurotransmitter secretion (GO:0007269) | 4.45118194 |
| 23 | * synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.42796861 |
| 24 | dendritic spine morphogenesis (GO:0060997) | 4.40316206 |
| 25 | neuron cell-cell adhesion (GO:0007158) | 4.36003594 |
| 26 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.27335851 |
| 27 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.23076704 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 4.20488205 |
| 29 | * synaptic transmission, glutamatergic (GO:0035249) | 4.19697297 |
| 30 | gamma-aminobutyric acid transport (GO:0015812) | 4.16545471 |
| 31 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.12331525 |
| 32 | amino acid import (GO:0043090) | 4.11701239 |
| 33 | long-term memory (GO:0007616) | 4.10604597 |
| 34 | positive regulation of membrane potential (GO:0045838) | 4.08148138 |
| 35 | proline transport (GO:0015824) | 3.99279292 |
| 36 | cellular potassium ion homeostasis (GO:0030007) | 3.99071342 |
| 37 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.94991361 |
| 38 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.93438490 |
| 39 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.91853957 |
| 40 | * neuron-neuron synaptic transmission (GO:0007270) | 3.89912442 |
| 41 | potassium ion homeostasis (GO:0055075) | 3.87393844 |
| 42 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.83649408 |
| 43 | positive regulation of synapse maturation (GO:0090129) | 3.83076419 |
| 44 | sodium ion export (GO:0071436) | 3.78612509 |
| 45 | neuromuscular process controlling balance (GO:0050885) | 3.77260993 |
| 46 | regulation of postsynaptic membrane potential (GO:0060078) | 3.76561292 |
| 47 | presynaptic membrane organization (GO:0097090) | 3.72220121 |
| 48 | presynaptic membrane assembly (GO:0097105) | 3.72011363 |
| 49 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.70066880 |
| 50 | activation of protein kinase A activity (GO:0034199) | 3.64688008 |
| 51 | potassium ion import (GO:0010107) | 3.64129650 |
| 52 | * regulation of synaptic plasticity (GO:0048167) | 3.63497026 |
| 53 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.58021620 |
| 54 | transmission of nerve impulse (GO:0019226) | 3.55344134 |
| 55 | * neurotransmitter transport (GO:0006836) | 3.53615017 |
| 56 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.53609125 |
| 57 | auditory behavior (GO:0031223) | 3.53171385 |
| 58 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.50539683 |
| 59 | neuron recognition (GO:0008038) | 3.49958704 |
| 60 | dendrite morphogenesis (GO:0048813) | 3.48228949 |
| 61 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.48202304 |
| 62 | synaptic vesicle endocytosis (GO:0048488) | 3.47274637 |
| 63 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.40476731 |
| 64 | neuromuscular synaptic transmission (GO:0007274) | 3.40040874 |
| 65 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.37524605 |
| 66 | * regulation of neurotransmitter secretion (GO:0046928) | 3.37072765 |
| 67 | prepulse inhibition (GO:0060134) | 3.36563099 |
| 68 | postsynaptic membrane organization (GO:0001941) | 3.35429951 |
| 69 | regulation of vesicle fusion (GO:0031338) | 3.34758100 |
| 70 | glycine transport (GO:0015816) | 3.31867595 |
| 71 | long-term synaptic potentiation (GO:0060291) | 3.30205206 |
| 72 | response to auditory stimulus (GO:0010996) | 3.30024547 |
| 73 | central nervous system myelination (GO:0022010) | 3.29830317 |
| 74 | axon ensheathment in central nervous system (GO:0032291) | 3.29830317 |
| 75 | regulation of ARF protein signal transduction (GO:0032012) | 3.29592361 |
| 76 | neuromuscular process controlling posture (GO:0050884) | 3.29373026 |
| 77 | cell communication by electrical coupling (GO:0010644) | 3.28805779 |
| 78 | * regulation of neurotransmitter levels (GO:0001505) | 3.28470685 |
| 79 | membrane depolarization during action potential (GO:0086010) | 3.28462347 |
| 80 | neuronal ion channel clustering (GO:0045161) | 3.27488657 |
| 81 | axonal fasciculation (GO:0007413) | 3.27076776 |
| 82 | cellular sodium ion homeostasis (GO:0006883) | 3.26328708 |
| 83 | membrane depolarization (GO:0051899) | 3.24603872 |
| 84 | positive regulation of dendritic spine development (GO:0060999) | 3.24413301 |
| 85 | dendritic spine organization (GO:0097061) | 3.23520126 |
| 86 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.21724869 |
| 87 | membrane hyperpolarization (GO:0060081) | 3.20989609 |
| 88 | regulation of dendritic spine development (GO:0060998) | 3.20010933 |
| 89 | vesicle transport along microtubule (GO:0047496) | 3.17266137 |
| 90 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.16049758 |
| 91 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.15890007 |
| 92 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.15742021 |
| 93 | acidic amino acid transport (GO:0015800) | 3.12767984 |
| 94 | * regulation of neurotransmitter transport (GO:0051588) | 3.12251125 |
| 95 | learning (GO:0007612) | 3.11531763 |
| 96 | neurotransmitter uptake (GO:0001504) | 3.11510822 |
| 97 | chemosensory behavior (GO:0007635) | 3.11008910 |
| 98 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.10748540 |
| 99 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.08667151 |
| 100 | detection of calcium ion (GO:0005513) | 3.08489931 |
| 101 | neuromuscular process (GO:0050905) | 3.08401470 |
| 102 | * positive regulation of neurotransmitter transport (GO:0051590) | 3.07997428 |
| 103 | serotonin metabolic process (GO:0042428) | 3.06481378 |
| 104 | synapse assembly (GO:0007416) | 3.05294338 |
| 105 | cell differentiation in hindbrain (GO:0021533) | 3.04743771 |
| 106 | social behavior (GO:0035176) | 3.04584811 |
| 107 | intraspecies interaction between organisms (GO:0051703) | 3.04584811 |
| 108 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.04559576 |
| 109 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.04111814 |
| 110 | establishment of synaptic vesicle localization (GO:0097480) | 3.03363057 |
| 111 | cell migration in hindbrain (GO:0021535) | 3.01670355 |
| 112 | behavioral defense response (GO:0002209) | 2.98711708 |
| 113 | behavioral fear response (GO:0001662) | 2.98711708 |
| 114 | * regulation of synaptic transmission (GO:0050804) | 2.98640597 |
| 115 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.96302812 |
| 116 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.95841869 |
| 117 | L-amino acid import (GO:0043092) | 2.93782830 |
| 118 | * synaptic transmission (GO:0007268) | 2.92114910 |
| 119 | regulation of synapse maturation (GO:0090128) | 2.91709977 |
| 120 | cerebellar Purkinje cell layer development (GO:0021680) | 2.91114074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.16488549 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.23270375 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11720187 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07355157 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.01216863 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.92656898 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.90458705 |
| 8 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.78242880 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.76974404 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.76974404 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.68818306 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.58809460 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.57152575 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54440624 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.48806797 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46208779 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42947056 |
| 18 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.36545505 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.33927696 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.33477788 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.26942824 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.24916836 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.22990772 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.19961032 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.15181684 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.12066499 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.11171951 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.96462167 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76111609 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.75251243 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.73083136 |
| 32 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58266715 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54630841 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54447099 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49046619 |
| 36 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.43310502 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39791442 |
| 38 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.39138169 |
| 39 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.38756305 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38500927 |
| 41 | KDM2B_26808549_Chip-Seq_K562_Human | 1.36091942 |
| 42 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30002964 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28179239 |
| 44 | AR_19668381_ChIP-Seq_PC3_Human | 1.25305445 |
| 45 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25217153 |
| 46 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.24194903 |
| 47 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22738403 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22713334 |
| 49 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22226598 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22117477 |
| 51 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.20064146 |
| 52 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.19665125 |
| 53 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.19589681 |
| 54 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.19333073 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17748609 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17735891 |
| 57 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.15172627 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15145016 |
| 59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12705360 |
| 60 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12337933 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12174735 |
| 62 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12018651 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10122927 |
| 64 | P300_19829295_ChIP-Seq_ESCs_Human | 1.07686500 |
| 65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07168006 |
| 66 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05965413 |
| 67 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.05211115 |
| 68 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.04516742 |
| 69 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03486739 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02940185 |
| 71 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02592078 |
| 72 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02290598 |
| 73 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02089378 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99918855 |
| 75 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.99823096 |
| 76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99273536 |
| 77 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99055545 |
| 78 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99055545 |
| 79 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98635465 |
| 80 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98394487 |
| 81 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.98146747 |
| 82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98136314 |
| 83 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.98100790 |
| 84 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96386823 |
| 85 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95624788 |
| 86 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95308898 |
| 87 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94904546 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94234982 |
| 89 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93981639 |
| 90 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93737328 |
| 91 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92972816 |
| 92 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92073553 |
| 93 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91624457 |
| 94 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91335365 |
| 95 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91201691 |
| 96 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.90972860 |
| 97 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90112701 |
| 98 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.90026060 |
| 99 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.87704905 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86976124 |
| 101 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86649974 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86532646 |
| 103 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.86484222 |
| 104 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.86331788 |
| 105 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.85589512 |
| 106 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85585611 |
| 107 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.85235663 |
| 108 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84807794 |
| 109 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84662435 |
| 110 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84052483 |
| 111 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83786814 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83431851 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82120053 |
| 114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.81800624 |
| 115 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.79835222 |
| 116 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77528870 |
| 117 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.77016241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.24516011 |
| 2 | MP0003880_abnormal_central_pattern | 4.50991430 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.28982182 |
| 4 | MP0004270_analgesia | 4.00132066 |
| 5 | MP0009745_abnormal_behavioral_response | 3.44430104 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.43766661 |
| 7 | MP0002064_seizures | 3.15828440 |
| 8 | MP0002822_catalepsy | 3.15480632 |
| 9 | MP0005423_abnormal_somatic_nervous | 3.09005536 |
| 10 | MP0009046_muscle_twitch | 3.08447666 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.97421763 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.80499112 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.74191149 |
| 14 | MP0001486_abnormal_startle_reflex | 2.59702714 |
| 15 | MP0002272_abnormal_nervous_system | 2.57883773 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.23137768 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.22398242 |
| 18 | MP0002736_abnormal_nociception_after | 2.15614556 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.15043201 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.05427843 |
| 21 | MP0002909_abnormal_adrenal_gland | 2.05006550 |
| 22 | MP0008569_lethality_at_weaning | 2.02589147 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.02425477 |
| 24 | MP0001970_abnormal_pain_threshold | 1.97556321 |
| 25 | MP0004858_abnormal_nervous_system | 1.93711693 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.89786203 |
| 27 | * MP0004811_abnormal_neuron_physiology | 1.87089546 |
| 28 | MP0002184_abnormal_innervation | 1.82220600 |
| 29 | MP0003329_amyloid_beta_deposits | 1.80628396 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.79526527 |
| 31 | MP0000778_abnormal_nervous_system | 1.77886711 |
| 32 | MP0003123_paternal_imprinting | 1.77697122 |
| 33 | MP0004924_abnormal_behavior | 1.70603620 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.70603620 |
| 35 | MP0003879_abnormal_hair_cell | 1.70139983 |
| 36 | MP0000955_abnormal_spinal_cord | 1.65096136 |
| 37 | MP0004885_abnormal_endolymph | 1.52865555 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.52616045 |
| 39 | MP0003787_abnormal_imprinting | 1.48559732 |
| 40 | * MP0002882_abnormal_neuron_morphology | 1.45301385 |
| 41 | * MP0002066_abnormal_motor_capabilities/c | 1.42289650 |
| 42 | MP0003633_abnormal_nervous_system | 1.40640951 |
| 43 | MP0001984_abnormal_olfaction | 1.36174474 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.34660021 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.32249238 |
| 46 | MP0006276_abnormal_autonomic_nervous | 1.30993348 |
| 47 | MP0008877_abnormal_DNA_methylation | 1.30731269 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.24668879 |
| 49 | MP0003631_nervous_system_phenotype | 1.16211963 |
| 50 | MP0003283_abnormal_digestive_organ | 1.15916557 |
| 51 | MP0002152_abnormal_brain_morphology | 1.13995699 |
| 52 | MP0004142_abnormal_muscle_tone | 1.07836388 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.04234922 |
| 54 | MP0002229_neurodegeneration | 1.00237304 |
| 55 | MP0003075_altered_response_to | 0.99916413 |
| 56 | MP0003121_genomic_imprinting | 0.99863244 |
| 57 | MP0001905_abnormal_dopamine_level | 0.99523045 |
| 58 | MP0001529_abnormal_vocalization | 0.99414327 |
| 59 | MP0008872_abnormal_physiological_respon | 0.98055055 |
| 60 | MP0001188_hyperpigmentation | 0.95350965 |
| 61 | MP0001177_atelectasis | 0.94531192 |
| 62 | * MP0002069_abnormal_eating/drinking_beha | 0.94160546 |
| 63 | MP0005551_abnormal_eye_electrophysiolog | 0.93986158 |
| 64 | MP0004145_abnormal_muscle_electrophysio | 0.93669017 |
| 65 | MP0008874_decreased_physiological_sensi | 0.92196655 |
| 66 | MP0003122_maternal_imprinting | 0.90236628 |
| 67 | MP0000013_abnormal_adipose_tissue | 0.85544365 |
| 68 | MP0004085_abnormal_heartbeat | 0.82784634 |
| 69 | MP0003634_abnormal_glial_cell | 0.82263808 |
| 70 | MP0010386_abnormal_urinary_bladder | 0.82219191 |
| 71 | MP0003690_abnormal_glial_cell | 0.81683394 |
| 72 | MP0003632_abnormal_nervous_system | 0.81293573 |
| 73 | MP0000751_myopathy | 0.80224389 |
| 74 | MP0005535_abnormal_body_temperature | 0.78926645 |
| 75 | MP0004742_abnormal_vestibular_system | 0.78458680 |
| 76 | MP0000920_abnormal_myelination | 0.78173316 |
| 77 | MP0000631_abnormal_neuroendocrine_gland | 0.77236882 |
| 78 | MP0000604_amyloidosis | 0.77153548 |
| 79 | MP0005499_abnormal_olfactory_system | 0.77093227 |
| 80 | MP0005394_taste/olfaction_phenotype | 0.77093227 |
| 81 | MP0002090_abnormal_vision | 0.76077100 |
| 82 | MP0004147_increased_porphyrin_level | 0.75792644 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.75285400 |
| 84 | MP0001348_abnormal_lacrimal_gland | 0.74409533 |
| 85 | MP0002752_abnormal_somatic_nervous | 0.71754938 |
| 86 | MP0004510_myositis | 0.71527404 |
| 87 | MP0001963_abnormal_hearing_physiology | 0.70744935 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.66312816 |
| 89 | MP0002638_abnormal_pupillary_reflex | 0.66056865 |
| 90 | MP0005409_darkened_coat_color | 0.64287240 |
| 91 | MP0004043_abnormal_pH_regulation | 0.61676755 |
| 92 | MP0004233_abnormal_muscle_weight | 0.61661846 |
| 93 | MP0003137_abnormal_impulse_conducting | 0.61482130 |
| 94 | MP0001485_abnormal_pinna_reflex | 0.59794765 |
| 95 | MP0003861_abnormal_nervous_system | 0.59618492 |
| 96 | MP0001346_abnormal_lacrimal_gland | 0.58905215 |
| 97 | MP0001299_abnormal_eye_distance/ | 0.58472676 |
| 98 | MP0005623_abnormal_meninges_morphology | 0.56682960 |
| 99 | MP0004215_abnormal_myocardial_fiber | 0.56597757 |
| 100 | MP0005187_abnormal_penis_morphology | 0.56573057 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.55718250 |
| 102 | MP0001664_abnormal_digestion | 0.55589381 |
| 103 | * MP0010769_abnormal_survival | 0.55008406 |
| 104 | * MP0001943_abnormal_respiration | 0.53237856 |
| 105 | MP0000579_abnormal_nail_morphology | 0.52879965 |
| 106 | * MP0010770_preweaning_lethality | 0.51539287 |
| 107 | * MP0002082_postnatal_lethality | 0.51539287 |
| 108 | * MP0010768_mortality/aging | 0.51436794 |
| 109 | MP0003956_abnormal_body_size | 0.51352086 |
| 110 | MP0004484_altered_response_of | 0.51123902 |
| 111 | MP0004130_abnormal_muscle_cell | 0.47143483 |
| 112 | MP0003938_abnormal_ear_development | 0.46719524 |
| 113 | MP0001731_abnormal_postnatal_growth | 0.45582314 |
| 114 | MP0000026_abnormal_inner_ear | 0.45158729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.40970389 |
| 2 | Focal motor seizures (HP:0011153) | 7.33595899 |
| 3 | Focal seizures (HP:0007359) | 5.76512063 |
| 4 | Visual hallucinations (HP:0002367) | 5.40097376 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.69731147 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.38335774 |
| 7 | Action tremor (HP:0002345) | 4.27404930 |
| 8 | Febrile seizures (HP:0002373) | 4.17661376 |
| 9 | Atonic seizures (HP:0010819) | 4.02624414 |
| 10 | Absence seizures (HP:0002121) | 3.89488498 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.86595224 |
| 12 | Ankle clonus (HP:0011448) | 3.76767741 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.76088213 |
| 14 | Poor eye contact (HP:0000817) | 3.64861593 |
| 15 | Broad-based gait (HP:0002136) | 3.62310932 |
| 16 | Papilledema (HP:0001085) | 3.58616204 |
| 17 | Dialeptic seizures (HP:0011146) | 3.56132180 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.49316392 |
| 19 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.45085548 |
| 20 | Depression (HP:0000716) | 3.41258231 |
| 21 | Mutism (HP:0002300) | 3.37166574 |
| 22 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.30089807 |
| 23 | Abnormal social behavior (HP:0012433) | 3.26963149 |
| 24 | Impaired social interactions (HP:0000735) | 3.26963149 |
| 25 | Dysdiadochokinesis (HP:0002075) | 3.22212038 |
| 26 | Dysmetria (HP:0001310) | 3.12124782 |
| 27 | Abnormality of the lower motor neuron (HP:0002366) | 3.07867176 |
| 28 | Genetic anticipation (HP:0003743) | 3.07164211 |
| 29 | Postural instability (HP:0002172) | 3.06686809 |
| 30 | Anxiety (HP:0000739) | 3.05640558 |
| 31 | Impaired smooth pursuit (HP:0007772) | 2.98610217 |
| 32 | Truncal ataxia (HP:0002078) | 2.96854079 |
| 33 | Tetraplegia (HP:0002445) | 2.91155575 |
| 34 | Amblyopia (HP:0000646) | 2.87967917 |
| 35 | Torticollis (HP:0000473) | 2.83199867 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.81120423 |
| 37 | Cerebral hypomyelination (HP:0006808) | 2.78803662 |
| 38 | Hemiparesis (HP:0001269) | 2.78368666 |
| 39 | Akinesia (HP:0002304) | 2.76723954 |
| 40 | Urinary urgency (HP:0000012) | 2.75987761 |
| 41 | Spastic gait (HP:0002064) | 2.73371352 |
| 42 | Abnormality of binocular vision (HP:0011514) | 2.71630890 |
| 43 | Diplopia (HP:0000651) | 2.71630890 |
| 44 | Intention tremor (HP:0002080) | 2.69249940 |
| 45 | Hemiplegia (HP:0002301) | 2.68706546 |
| 46 | Stereotypic behavior (HP:0000733) | 2.63618462 |
| 47 | Hyperventilation (HP:0002883) | 2.63036315 |
| 48 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.60869204 |
| 49 | Focal dystonia (HP:0004373) | 2.60759805 |
| 50 | Scanning speech (HP:0002168) | 2.60551201 |
| 51 | Excessive salivation (HP:0003781) | 2.60493325 |
| 52 | Drooling (HP:0002307) | 2.60493325 |
| 53 | Neurofibrillary tangles (HP:0002185) | 2.55326024 |
| 54 | Megalencephaly (HP:0001355) | 2.54340035 |
| 55 | Bradykinesia (HP:0002067) | 2.52780283 |
| 56 | Ventricular fibrillation (HP:0001663) | 2.50926523 |
| 57 | Epileptiform EEG discharges (HP:0011182) | 2.50206691 |
| 58 | Sleep apnea (HP:0010535) | 2.50004632 |
| 59 | Cerebral inclusion bodies (HP:0100314) | 2.44560904 |
| 60 | EEG with generalized epileptiform discharges (HP:0011198) | 2.44481067 |
| 61 | Insomnia (HP:0100785) | 2.41628122 |
| 62 | Annular pancreas (HP:0001734) | 2.41283732 |
| 63 | Spastic tetraparesis (HP:0001285) | 2.36756581 |
| 64 | Dysmetric saccades (HP:0000641) | 2.36673669 |
| 65 | Hypsarrhythmia (HP:0002521) | 2.36029063 |
| 66 | Pointed chin (HP:0000307) | 2.35648269 |
| 67 | Impaired vibratory sensation (HP:0002495) | 2.34397025 |
| 68 | Progressive inability to walk (HP:0002505) | 2.33363044 |
| 69 | Abnormality of the corticospinal tract (HP:0002492) | 2.32375803 |
| 70 | Agitation (HP:0000713) | 2.31204688 |
| 71 | Craniofacial dystonia (HP:0012179) | 2.30812535 |
| 72 | Obstructive sleep apnea (HP:0002870) | 2.28482769 |
| 73 | Delusions (HP:0000746) | 2.27418156 |
| 74 | Termporal pattern (HP:0011008) | 2.23410280 |
| 75 | Insidious onset (HP:0003587) | 2.23410280 |
| 76 | Lower limb muscle weakness (HP:0007340) | 2.22911290 |
| 77 | Status epilepticus (HP:0002133) | 2.18517185 |
| 78 | Limb dystonia (HP:0002451) | 2.17257606 |
| 79 | Absent speech (HP:0001344) | 2.17197611 |
| 80 | Amyotrophic lateral sclerosis (HP:0007354) | 2.15494898 |
| 81 | Clonus (HP:0002169) | 2.11401838 |
| 82 | Fetal akinesia sequence (HP:0001989) | 2.08909801 |
| 83 | Inappropriate behavior (HP:0000719) | 2.06632301 |
| 84 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.05590092 |
| 85 | Bundle branch block (HP:0011710) | 2.05544263 |
| 86 | Neuronal loss in central nervous system (HP:0002529) | 2.04307002 |
| 87 | Peripheral hypomyelination (HP:0007182) | 2.02605427 |
| 88 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.01855707 |
| 89 | Generalized myoclonic seizures (HP:0002123) | 1.99736712 |
| 90 | Bronchomalacia (HP:0002780) | 1.99651037 |
| 91 | Choreoathetosis (HP:0001266) | 1.99318125 |
| 92 | Apathy (HP:0000741) | 1.98861746 |
| 93 | Pheochromocytoma (HP:0002666) | 1.97222570 |
| 94 | Lower limb amyotrophy (HP:0007210) | 1.96839791 |
| 95 | Gait ataxia (HP:0002066) | 1.95682445 |
| 96 | Incomplete penetrance (HP:0003829) | 1.90363786 |
| 97 | Abnormal EKG (HP:0003115) | 1.89313485 |
| 98 | CNS hypomyelination (HP:0003429) | 1.88870544 |
| 99 | Increased circulating renin level (HP:0000848) | 1.88830964 |
| 100 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.88772313 |
| 101 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.88772313 |
| 102 | Inability to walk (HP:0002540) | 1.85370680 |
| 103 | Abnormality of saccadic eye movements (HP:0000570) | 1.83931321 |
| 104 | Ankyloglossia (HP:0010296) | 1.83411628 |
| 105 | Polyphagia (HP:0002591) | 1.82988874 |
| 106 | Resting tremor (HP:0002322) | 1.80220418 |
| 107 | Lower limb asymmetry (HP:0100559) | 1.80046959 |
| 108 | Turricephaly (HP:0000262) | 1.79945421 |
| 109 | Rigidity (HP:0002063) | 1.79683529 |
| 110 | Blue irides (HP:0000635) | 1.78317455 |
| 111 | Spastic tetraplegia (HP:0002510) | 1.77446721 |
| 112 | Aqueductal stenosis (HP:0002410) | 1.76574026 |
| 113 | Rapidly progressive (HP:0003678) | 1.75474518 |
| 114 | Intellectual disability, profound (HP:0002187) | 1.73034880 |
| 115 | Diminished motivation (HP:0000745) | 1.72850907 |
| 116 | Psychosis (HP:0000709) | 1.70725278 |
| 117 | Paraplegia (HP:0010550) | 1.68042141 |
| 118 | Muscular hypotonia of the trunk (HP:0008936) | 1.63776668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.51840678 |
| 2 | NTRK3 | 4.51679781 |
| 3 | MAP3K9 | 4.11701677 |
| 4 | MARK1 | 3.63712444 |
| 5 | MAP3K4 | 2.86093009 |
| 6 | DAPK2 | 2.86003563 |
| 7 | MINK1 | 2.77784985 |
| 8 | PAK6 | 2.48428683 |
| 9 | PRKD3 | 2.47748138 |
| 10 | MAP2K7 | 2.29180555 |
| 11 | KSR2 | 2.20500150 |
| 12 | NTRK2 | 2.17052459 |
| 13 | CAMKK1 | 2.13525759 |
| 14 | NTRK1 | 1.98212360 |
| 15 | MAP2K4 | 1.69598311 |
| 16 | RIPK4 | 1.66744551 |
| 17 | CDK5 | 1.64111545 |
| 18 | DAPK1 | 1.63301706 |
| 19 | KSR1 | 1.57778519 |
| 20 | TNIK | 1.50947387 |
| 21 | SIK2 | 1.48619492 |
| 22 | STK38 | 1.47965044 |
| 23 | PRPF4B | 1.38785329 |
| 24 | MAP3K2 | 1.33227217 |
| 25 | FES | 1.30819510 |
| 26 | MAPK13 | 1.29006322 |
| 27 | TAOK1 | 1.26761380 |
| 28 | MAP3K12 | 1.25639747 |
| 29 | CAMK1D | 1.24000013 |
| 30 | UHMK1 | 1.23025862 |
| 31 | TYRO3 | 1.22524358 |
| 32 | GRK5 | 1.17993006 |
| 33 | PRKCG | 1.17420733 |
| 34 | CAMKK2 | 1.15670413 |
| 35 | PNCK | 1.13992578 |
| 36 | CDK19 | 1.12721636 |
| 37 | CASK | 1.09112683 |
| 38 | PLK2 | 1.09106191 |
| 39 | CAMK1 | 1.05707167 |
| 40 | PHKG2 | 1.04921541 |
| 41 | PHKG1 | 1.04921541 |
| 42 | ALK | 1.01433776 |
| 43 | STK11 | 1.01265659 |
| 44 | MAP3K13 | 0.98319600 |
| 45 | ARAF | 0.97993249 |
| 46 | RET | 0.96419038 |
| 47 | PRKCH | 0.94660156 |
| 48 | LATS2 | 0.93467546 |
| 49 | CDK15 | 0.90279093 |
| 50 | CDK18 | 0.89864036 |
| 51 | CAMK2A | 0.87789452 |
| 52 | FGFR2 | 0.86449861 |
| 53 | CDK14 | 0.85733297 |
| 54 | MARK2 | 0.85646045 |
| 55 | SGK494 | 0.84295047 |
| 56 | SGK223 | 0.84295047 |
| 57 | RIPK1 | 0.82215968 |
| 58 | RAF1 | 0.78958801 |
| 59 | CDK11A | 0.78557805 |
| 60 | PAK3 | 0.73104527 |
| 61 | PINK1 | 0.72855677 |
| 62 | DYRK1A | 0.72820840 |
| 63 | CSNK1G2 | 0.69831952 |
| 64 | SGK1 | 0.69693367 |
| 65 | CAMK2B | 0.68437511 |
| 66 | PDK1 | 0.68258398 |
| 67 | SGK2 | 0.68134543 |
| 68 | SGK3 | 0.67757244 |
| 69 | CDC42BPA | 0.65644809 |
| 70 | MAP3K1 | 0.64250665 |
| 71 | PKN1 | 0.62828144 |
| 72 | PDPK1 | 0.62000859 |
| 73 | SCYL2 | 0.60803804 |
| 74 | LMTK2 | 0.59849041 |
| 75 | CAMK1G | 0.57880624 |
| 76 | PTK2B | 0.57439338 |
| 77 | BRAF | 0.57238278 |
| 78 | BRSK1 | 0.54841669 |
| 79 | RPS6KA3 | 0.54167805 |
| 80 | PRKCZ | 0.53304894 |
| 81 | CAMK4 | 0.51761696 |
| 82 | MAPK12 | 0.50474044 |
| 83 | BMPR2 | 0.50276907 |
| 84 | FYN | 0.49888896 |
| 85 | MAP3K7 | 0.49384608 |
| 86 | TNK2 | 0.48349837 |
| 87 | DYRK2 | 0.47432217 |
| 88 | NEK6 | 0.47028648 |
| 89 | MAPK10 | 0.46805666 |
| 90 | NEK1 | 0.46143280 |
| 91 | DAPK3 | 0.45278733 |
| 92 | OXSR1 | 0.44248765 |
| 93 | CSNK1E | 0.43765005 |
| 94 | WNK1 | 0.40459249 |
| 95 | DMPK | 0.40093517 |
| 96 | RPS6KA2 | 0.39457841 |
| 97 | PRKCE | 0.38955792 |
| 98 | CSNK1D | 0.37668746 |
| 99 | CAMK2D | 0.37416145 |
| 100 | ROCK2 | 0.36227406 |
| 101 | FER | 0.36051860 |
| 102 | MAP2K1 | 0.34591267 |
| 103 | GSK3B | 0.33885200 |
| 104 | PRKCB | 0.33848767 |
| 105 | CSNK1G3 | 0.33416530 |
| 106 | MAP3K6 | 0.33058024 |
| 107 | PRKCA | 0.32897571 |
| 108 | CAMK2G | 0.32125660 |
| 109 | ERBB2 | 0.31665011 |
| 110 | CCNB1 | 0.31645427 |
| 111 | LIMK1 | 0.30798670 |
| 112 | PRKDC | 0.29999161 |
| 113 | ICK | 0.29491232 |
| 114 | WNK3 | 0.29479158 |
| 115 | MAP2K6 | 0.29094901 |
| 116 | PRKD2 | 0.28362367 |
| 117 | MAPK8 | 0.28340460 |
| 118 | CSNK1A1 | 0.27413621 |
| 119 | PRKG1 | 0.27147205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.45900602 |
| 2 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.06609057 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.79659662 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.78008441 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.69893220 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.65447963 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.64303730 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.56993269 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.48408267 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.46181938 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.29410429 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19997873 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.15845981 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.14893121 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.02781337 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.95795591 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.90920410 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.72714516 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.71438743 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.69995577 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.67682470 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.63219558 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.62277339 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.62227617 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.56475137 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.55068459 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.51749343 |
| 28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.46464047 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.45174485 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41475536 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.36414007 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.32055078 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31422887 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.26962409 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23006173 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.21122901 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.18095975 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16442157 |
| 39 | Axon guidance_Homo sapiens_hsa04360 | 1.13347398 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.11507924 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06749632 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04845835 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.04099511 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96049566 |
| 45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94391388 |
| 46 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91427846 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91172426 |
| 48 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89949608 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89577069 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88623508 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86059643 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 0.84380845 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80567459 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79781323 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79259309 |
| 56 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78745129 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76754265 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76290460 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75463863 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73650159 |
| 61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72487781 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72200978 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70865970 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70434378 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68332073 |
| 66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67836031 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64428125 |
| 68 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60933439 |
| 69 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60861991 |
| 70 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60058947 |
| 71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59707937 |
| 72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58824160 |
| 73 | Alcoholism_Homo sapiens_hsa05034 | 0.58772662 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58066600 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57465764 |
| 76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56791877 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.55992369 |
| 78 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.53892892 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52245343 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51837506 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.50869353 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50089227 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49565085 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48893215 |
| 85 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46753343 |
| 86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.46608510 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46136328 |
| 88 | Tight junction_Homo sapiens_hsa04530 | 0.45886598 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43985317 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43043918 |
| 91 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42447020 |
| 92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40798481 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.39787048 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37777646 |
| 95 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.35755083 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35258402 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35230389 |
| 98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35141318 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34573575 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34468995 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34041680 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32786684 |
| 103 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32547866 |
| 104 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32382135 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31458151 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29530606 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28344597 |
| 108 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.28082716 |
| 109 | Alzheimers disease_Homo sapiens_hsa05010 | 0.27621946 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.27100620 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25734678 |
| 112 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.25473631 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.24517838 |
| 114 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.24058829 |
| 115 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15481495 |

